UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Separate elements of episodic memory subserved by distinct hippocampal-prefrontal connections

Nature neuroscience, 2017-02, Vol.20 (2), p.242-250

2017

Volltextzugriff (PDF)

Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease

Human gene therapy. Clinical development, 2018-09, Vol.29 (3), p.148-155

2018

Volltextzugriff (PDF)

Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia

Science translational medicine, 2009-10, Vol.1 (2), p.2ra4

2009

Volltextzugriff (PDF)

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

Nature medicine, 2005-04, Vol.11 (43), p.429-433

2005

Volltextzugriff (PDF)

Removal of AMPA Receptors (AMPARs) from Synapses Is Preceded by Transient Endocytosis of Extrasynaptic AMPARs

The Journal of neuroscience, 2004-06, Vol.24 (22), p.5172-5176

2004

Volltextzugriff (PDF)

Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy

The Journal of clinical investigation, 2004-12, Vol.114 (12), p.1726-1731

2004

Volltextzugriff (PDF)

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

The Lancet (British edition), 2014-03, Vol.383 (9923), p.1138-1146

2014

Volltextzugriff (PDF)

Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors

Clinical science (1979), 2006-01, Vol.110 (1), p.37-46

2006

Volltextzugriff (PDF)

VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

Nature, 2004-05, Vol.429 (6990), p.413-417

2004

Volltextzugriff (PDF)

Lentiviral-Mediated Delivery of Bcl-2 or GDNF Protects against Excitotoxicity in the Rat Hippocampus

Molecular therapy, 2005-01, Vol.11 (1), p.89-95

2005

Volltextzugriff (PDF)

Gene Therapy for Parkinson’s Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis

Molecular therapy. Methods & clinical development, 2019-09, Vol.14, p.206-216

2019

Volltextzugriff (PDF)

A stable producer cell line for the manufacture of a lentiviral vector for gene therapy of Parkinson's disease

Human gene therapy, 2011-03, Vol.22 (3), p.357-369

2011

Volltextzugriff (PDF)

Optimizing Transgene Configuration and Protein Fusions to Maximize Dopamine Production for the Gene Therapy of Parkinson's Disease

Human gene therapy. Clinical development, 2016-09, Vol.27 (3), p.100-110

2016

Volltextzugriff (PDF)

Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons

Molecular and cellular neuroscience, 2003, Vol.22 (1), p.98-106

2003

Volltextzugriff (PDF)

Therapeutic gene silencing in neurological disorders, using interfering RNA

Journal of molecular medicine (Berlin, Germany), 2005-06, Vol.83 (6), p.413-419

2005

Volltextzugriff (PDF)

Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors

Neuroreport, 2000-06, Vol.11 (9), p.2051-2055

2000

Volltextzugriff (PDF)

Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy

The Journal of clinical investigation, 2004-12, Vol.114 (12), p.1726-1731

2004

Volltextzugriff (PDF)

Surface expression of AMPA receptors in hippocampal neurons is regulated by an NSF-dependent mechanism

Neuron (Cambridge, Mass.), 1999-06, Vol.23 (2), p.365-376

1999

Volltextzugriff (PDF)

Traitement de la maladie de Parkinson par thérapie génique de la dopamine (ProSavin®) résultats d’un essai clinique de phase I

Revue neurologique, 2013-04, Vol.169, p.A224-A225

2013

Volltextzugriff (PDF)

Choosing to Lead: Understanding Congressional Foreign Policy Entrepreneurs

1, 2009

Volltextzugriff (PDF)

REGULATION OF AMPA RECEPTOR SURFACE EXPRESSION BY A NSF-DEPENDENT MECHANISM IN HIPPOCAMPAL NEURONS IN CULTURE

Biochemical Society transactions, 1999-06, Vol.27 (3), p.A117-A117

1999

Volltextzugriff (PDF)

The Quaker Settlement of Wrightsborough, Georgia

The Georgia historical quarterly, 1972-07, Vol.56 (2), p.210-223

Scott, Ralph C.

1972

Volltextzugriff (PDF)

Choosing to Lead: Understanding Congressional Foreign Policy Entrepreneurs

Perspectives on Politics, 2010, Vol.8 (3), p.951-952

Kriner, Douglas L.

2010

Volltextzugriff (PDF)

The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation

The Annals of thoracic surgery, 2017, Vol.103 (1), p.329-341

2017

Volltextzugriff (PDF)

Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections

The New England journal of medicine, 2014-06, Vol.370 (23), p.2180-2190

2014

Volltextzugriff (PDF)

1 – 25 von 706

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(594)
Mit Volltextzugriff
(598)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Separate elements of episodic memory subserved by distinct hippocampal-prefrontal connections

Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease

Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

Removal of AMPA Receptors (AMPARs) from Synapses Is Preceded by Transient Endocytosis of Extrasynaptic AMPARs

Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors

VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

Lentiviral-Mediated Delivery of Bcl-2 or GDNF Protects against Excitotoxicity in the Rat Hippocampus

Gene Therapy for Parkinson’s Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis

A stable producer cell line for the manufacture of a lentiviral vector for gene therapy of Parkinson's disease

Optimizing Transgene Configuration and Protein Fusions to Maximize Dopamine Production for the Gene Therapy of Parkinson's Disease

Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons

Therapeutic gene silencing in neurological disorders, using interfering RNA

Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors

Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy

Surface expression of AMPA receptors in hippocampal neurons is regulated by an NSF-dependent mechanism

Traitement de la maladie de Parkinson par thérapie génique de la dopamine (ProSavin®) résultats d’un essai clinique de phase I

Choosing to Lead: Understanding Congressional Foreign Policy Entrepreneurs

REGULATION OF AMPA RECEPTOR SURFACE EXPRESSION BY A NSF-DEPENDENT MECHANISM IN HIPPOCAMPAL NEURONS IN CULTURE

The Quaker Settlement of Wrightsborough, Georgia

Choosing to Lead: Understanding Congressional Foreign Policy Entrepreneurs

The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation

Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections

Suchergebnisse filtern